A magnetic resonance imaging (MRI) exam was performed in an 11-month-old female patient with West syndrome who had been treated with vigabatrin for five months (131.5 mg/kg/day). The MRI showed asymptomatic changes ( Figures 1, 2 and 3 ). Vigabatrin-associated MRI abnormalities occur in 10-20% of treated infants 1, 2 . Animal studies have associated the use of vigabatrin with histopathologic abnormalities showing microvacuolization of glial cells and intramyelinic edema 3, 4 . Neurologists and neuroradiologists should be aware of, and recognize these changes, as they are mostly transient and may be symptomatic or not. Asymptomatic abnormalities revealed on MRI appear to be dose dependent, according to recent studies 5 . 
